•
Dec 31, 2022

Sanara MedTech Q4 2022 Earnings Report

Announced strategic, operational and financial results for the quarter and full year ended December 31, 2022.

Key Takeaways

Sanara MedTech Inc. reported record sales results in both the fourth quarter and the full year, driven by the expansion of its sales team's geographic coverage, increased average sales per facility, and an expanded product line.

Expanded geographic coverage of sales team.

Increased average sales per facility.

Offered an expanded line of products.

Achieved record sales results in both the fourth quarter and the full year.

Total Revenue
$15.3M
Previous year: $7.03M
+117.8%
EPS
-$0.51
Previous year: -$0.48
+6.3%
Gross Profit
$12.9M
Previous year: $6.25M
+107.1%
Cash and Equivalents
$8.96M
Previous year: $18.7M
-52.0%
Free Cash Flow
-$698K
Previous year: -$1.93M
-63.7%
Total Assets
$61M
Previous year: $36.4M
+67.7%

Sanara MedTech

Sanara MedTech

Forward Guidance

The company is focused on improving patient outcomes through evidence-based healing solutions and is actively seeking to expand within its six focus areas of wound and skin care for the acute, post-acute, and surgical markets.